levofloxacin has been researched along with guaifenesin in 5 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (guaifenesin) | Trials (guaifenesin) | Recent Studies (post-2010) (guaifenesin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 11,152 | 362 | 2,987 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y | 1 |
| Aoun, V; Chain, JL; Del'Orto, JC; Derbali, RM; Frei, G; Hildgen, P; Moussa, G; Roullin, VG; Tehrani, SF | 1 |
1 review(s) available for levofloxacin and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for levofloxacin and guaifenesin
| Article | Year |
|---|---|
[Effects of levofloxacin once-a-day therapy on uterine cervicitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chlamydia Infections; Drug Administration Schedule; Female; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Middle Aged; Mucus; Ofloxacin; Uterine Cervicitis | 1999 |
3 other study(ies) available for levofloxacin and guaifenesin
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
Topics: A549 Cells; Anti-Bacterial Agents; Cell Survival; Cystic Fibrosis; Delayed-Action Preparations; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Drug Stability; Humans; Levofloxacin; Liposomes; Microbial Sensitivity Tests; Mucus; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |